Effect of Dihydroergotamine on Coagulation Factors and Components of the Fibrinolytic System

References

• Fagerhol M. K., Abildgaard U. Immunological Studies on Human Antithrombin III. Influence of Age, Sex and Use of Oral Contraceptives on Serum Concentration. Scand J Haematol 1970; 7: 10
   Google Scholar
• Ganrot P. O. Determination of α2-macroglobulin as trypsinprotein esterase. Clin Chim Acta 1966; 14: 493
   PubMed Web of Science ®Google Scholar
• Ganrot P. O., Niléhn J. E. Immunochemical determination of human plasminogen. Clin Chim Acta 1968; 22: 335
   PubMed Web of Science ®Google Scholar
• Genton E. Rationale for low dose heparin therapy. In Postoperative Thromboembolie-Prophylaxe. F. K. Schattauer Verlag, Stuttgart-New York 1977; 59
   Google Scholar
• Holmberg L., Nilsson I. M. Genetic variants of von Willebrands disease. Br Med J 1972; 3: 317
   PubMedGoogle Scholar
• Holmberg L., Nilsson I. M. AHF related protein in clinical praxis. Scand J Haematol 1974; 12: 221
   Google Scholar
• HörButtermann G., Theisinger G. W., Prabst H. W. Prevention of postoperative thromboembolism by various tretment. Eur J Nucl Med 1976; 1: 197
   Google Scholar
• Isacson S., Nilsson I. M. Defective Fibrinolysis in Blood and Vein Walls in Recurrent “Idiopathic” Venous Thrombosis. Acta Chir Scand 1972; 138: 313
   PubMedGoogle Scholar
• Kakkar V. V. Potentiation of anti Xa activity—another aspect of the synergistic effect of heparin and dihydroergot. Postoperative Thromboembolie-Profylaxe. F. K. Schattauer Verlag, Stuttgart-New York 1977; 183
   Google Scholar
• Mellander S., Nordenfelt I. Comparative effects of dihydroergotamine and noradrenaline on resistence, exchange and capitance functions in the peripheral circulation. Clin Sci 1970; 39: 183
   PubMed Web of Science ®Google Scholar
• Müller-Schweinitzer E. Studies on the peripheral mode of action of dihydroergotamine in human and canine veins. Eur J Pharmacol 1974; 27: 231
   Google Scholar
• Niléhn J. E. Separation and estimation of “split products” of fibrinogen and fibrin in human serum. Tromb Diath Haemorrh 1967; 18: 487
   PubMedGoogle Scholar
• Nilsson Blomb I.M., äck B., von Francken I. On an inherited autosomal haemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 159: 35
   PubMedGoogle Scholar
• Nilsson I. M., Olow B. Determination of fibrinogen and fibrinogenolytic activity. Thromb Diath Haemorrh 1962; 8: 297
   PubMedGoogle Scholar
• Nilsson Blomb I.M., äckRamgren M. O., von Francken I. Haemophilia in Sweden. II Carriers of haemophilia A and B. Acta Med Scand 1962; 171: 223
   Google Scholar
• Nordenfelt I., Mellander S. Central haemodynamic effects of dihydroergotamine in patients with orthostatic hypotension. Acta Med Scand 1972; 191: 115
   PubMedGoogle Scholar
• Owren P. A., Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951; 3: 201
   PubMed Web of Science ®Google Scholar
• Pandolfi M., Nilsson I. M. On coagulation and fibrinolysis in trauma and shock. Eur Surg Res 1972; 4: 153
   Google Scholar
• Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest 1962; 14: 138
   PubMed Web of Science ®Google Scholar
• Rieckert H. Die Pharmakodynamik des Dihydroergotamins. In Postoperative Thromboembolie-Prophylaxe. F. K. Schattauer Verlag, Stuttgart-New York 1977; 69
   Google Scholar
• Sagar Stamatakis S., Higgins J. D., Nairn A. F., Maffei D., Thomas F. H.D. P., Kakkar V. V. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total hip replacement. Lancet 1976; 1: 1151
   PubMed Web of Science ®Google Scholar
• Stammatakis Kakkar J.D., Lawrence V. V.D. L., Ward V. P. Synergistic effect of heparin and dihydroergotamine in the prophylaxis of postoperative deep vein thrombosis. Postoperative Thromboembolie-Prophylaxe. F. K. Schattauer Verlag, Stuttgart-New York 1977; 109
   Google Scholar
• Todd A. S. The histological localisation of fibrinolysin activator. J Pathol Bacteriol 1959; 78: 281
   PubMedGoogle Scholar
• Wolf P. A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma. J Clin Pathol 1953; 6: 34
   PubMed Web of Science ®Google Scholar
• åberg M., Nilsson I. M. Fibrinolytic activity of the vein wall after surgery. Br J Surg 1978; 65: 259
   PubMed Web of Science ®Google Scholar